Shenzhen, 10 August 2026 – Chinese researchers have released an open-source artificial-intelligence system designed to connect genomic data with clinical evidence, potentially shortening the years-long search for answers faced by many rare-disease patients.
The OneGenome platform combines a genomic foundation model with large-language-model capabilities. Rather than simply reading DNA sequences, it is intended to reason about how genetic mutations may contribute to disease and identify possible diagnostic or treatment pathways.
Unlock the Full Article
This article is exclusive to The Ledger Asia Subsribers / PAID members.
Already have an account? Log in here
This content has been restricted to logged-in users only. Please log in to view this content.